University of Hertfordshire

From the same journal

By the same authors

Easy to Swallow “Instant” Jelly Formulations for Sustained Release Gliclazide Delivery

Research output: Contribution to journalArticlepeer-review

Standard

Easy to Swallow “Instant” Jelly Formulations for Sustained Release Gliclazide Delivery. / Patel, Simmi; Scott, Nathan; Patel, Kavil; Mohylyuk, Valentyn; McAuley, William; Liu, Fang.

In: Journal of Pharmaceutical Sciences, 29.04.2020.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Bibtex

@article{2d78990877ed4cfa8e343a6aa572d4db,
title = "Easy to Swallow “Instant” Jelly Formulations for Sustained Release Gliclazide Delivery",
abstract = "It is a challenge to safely administer sustained release medicines to patients with dysphagia. Sustained release tablets must not be crushed and multiparticulates with large particle sizes cause gritiness reducing patient acceptability. The aim of this study was to develop “instant” jellies as delivery vehicles incorporating sustained release microparticles for patients with dysphagia. Dry powder mixtures containing gelling agents such as sodium alginate and calcium ions were hydrated in 20 mL of water and formed a jelly texture within 10 min. The “instant” jellies demonstrated comparable properites to commercial “read-to-eat” jellies in appearance, rheological/textural properties and in vitro swallowing performance in an artificial throat model. Gliclazide sustained release microparticles were produced by fluidized bed coating using Eudragit{\textregistered} NM 30 D and achieved 99% production yield and final coated particle size (D50) of 198  4.3 µm. Sustained gliclazide release was achieved over 15 h and the incorporation of the particles into the jellies significantly decreased the drug release rate. This novel drug delivery system offers a patient-centric solution to the long-standing challenge of administering sustained release medicines to patients with dysphagia and can potentially be used for paediatric patients. ",
author = "Simmi Patel and Nathan Scott and Kavil Patel and Valentyn Mohylyuk and William McAuley and Fang Liu",
note = "{\textcopyright} 2020 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association{\textregistered}. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).",
year = "2020",
month = apr,
day = "29",
doi = "10.1016/j.xphs.2020.04.018",
language = "English",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",

}

RIS

TY - JOUR

T1 - Easy to Swallow “Instant” Jelly Formulations for Sustained Release Gliclazide Delivery

AU - Patel, Simmi

AU - Scott, Nathan

AU - Patel, Kavil

AU - Mohylyuk, Valentyn

AU - McAuley, William

AU - Liu, Fang

N1 - © 2020 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association®. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PY - 2020/4/29

Y1 - 2020/4/29

N2 - It is a challenge to safely administer sustained release medicines to patients with dysphagia. Sustained release tablets must not be crushed and multiparticulates with large particle sizes cause gritiness reducing patient acceptability. The aim of this study was to develop “instant” jellies as delivery vehicles incorporating sustained release microparticles for patients with dysphagia. Dry powder mixtures containing gelling agents such as sodium alginate and calcium ions were hydrated in 20 mL of water and formed a jelly texture within 10 min. The “instant” jellies demonstrated comparable properites to commercial “read-to-eat” jellies in appearance, rheological/textural properties and in vitro swallowing performance in an artificial throat model. Gliclazide sustained release microparticles were produced by fluidized bed coating using Eudragit® NM 30 D and achieved 99% production yield and final coated particle size (D50) of 198  4.3 µm. Sustained gliclazide release was achieved over 15 h and the incorporation of the particles into the jellies significantly decreased the drug release rate. This novel drug delivery system offers a patient-centric solution to the long-standing challenge of administering sustained release medicines to patients with dysphagia and can potentially be used for paediatric patients.

AB - It is a challenge to safely administer sustained release medicines to patients with dysphagia. Sustained release tablets must not be crushed and multiparticulates with large particle sizes cause gritiness reducing patient acceptability. The aim of this study was to develop “instant” jellies as delivery vehicles incorporating sustained release microparticles for patients with dysphagia. Dry powder mixtures containing gelling agents such as sodium alginate and calcium ions were hydrated in 20 mL of water and formed a jelly texture within 10 min. The “instant” jellies demonstrated comparable properites to commercial “read-to-eat” jellies in appearance, rheological/textural properties and in vitro swallowing performance in an artificial throat model. Gliclazide sustained release microparticles were produced by fluidized bed coating using Eudragit® NM 30 D and achieved 99% production yield and final coated particle size (D50) of 198  4.3 µm. Sustained gliclazide release was achieved over 15 h and the incorporation of the particles into the jellies significantly decreased the drug release rate. This novel drug delivery system offers a patient-centric solution to the long-standing challenge of administering sustained release medicines to patients with dysphagia and can potentially be used for paediatric patients.

U2 - 10.1016/j.xphs.2020.04.018

DO - 10.1016/j.xphs.2020.04.018

M3 - Article

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

ER -